XML 77 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables)
12 Months Ended
Dec. 31, 2019
Revenues by major payor [Abstract]  
Schedule of Revenue Sources, Health Care Organization [Table Text Block]
The following table summarizes the Company's segment revenues by primary payor source:
 
Year ended December 31, 2019
 
U.S. dialysis
 
Other - Ancillary services
 
Consolidated
Patient service revenues:
 
 
 
 
 
Medicare and Medicare Advantage
$
6,129,697

 
$
 
$
6,129,697

Medicaid and Managed Medicaid
669,089

 

 
669,089

Other government
446,010

 
352,765

 
798,775

Commercial
3,286,089

 
144,256

 
3,430,345

Other revenues:
 
 
 
 
 
Medicare and Medicare Advantage

 
264,538

 
264,538

Medicaid and Managed Medicaid

 
606

 
606

Commercial

 
130,823

 
130,823

Other(1)
32,021

 
78,940

 
110,961

Eliminations of intersegment revenues
(132,325
)
 
(14,030
)
 
(146,355
)
Total
$
10,430,581

 
$
957,898

 
$
11,388,479

 
(1)
Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.
 
Year ended December 31, 2018
 
U.S. dialysis
 
Other - Ancillary services
 
Consolidated
Patient service revenues:
 
 
 
 
 
Medicare and Medicare Advantage
$
6,063,891

 
$
 
$
6,063,891

Medicaid and Managed Medicaid
628,766

 

 
628,766

Other government
446,999

 
335,594

 
782,593

Commercial
3,176,413

 
101,681

 
3,278,094

Other revenues:
 
 
 
 
 
Medicare and Medicare Advantage

 
492,812

 
492,812

Medicaid and Managed Medicaid

 
44,246

 
44,246

Commercial

 
90,890

 
90,890

Other(1)
19,880

 
130,865

 
150,745

Eliminations of intersegment revenues
(92,950
)
 
(34,236
)
 
(127,186
)
Total
$
10,242,999

 
$
1,161,852

 
$
11,404,851

 
(1)
Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.
 
Year ended December 31, 2017(1)
 
U.S. dialysis
 
Other - Ancillary services
 
Consolidated
Patient service revenues:
 
 
 
 
 
Medicare and Medicare Advantage
$
5,253,012

 
$
 
$
5,253,012

Medicaid and Managed Medicaid
606,827

 

 
606,827

Other government
362,567

 
259,651

 
622,218

Commercial
3,117,920

 
63,505

 
3,181,425

Other revenues:
 
 
 
 
 
Medicare and Medicare Advantage

 
902,289

 
902,289

Medicaid and Managed Medicaid

 
71,426

 
71,426

Commercial

 
116,503

 
116,503

Other(2)
19,739

 
182,974

 
202,713

Eliminations of intersegment revenues
(55,176
)
 
(24,603
)
 
(79,779
)
Total
$
9,304,889

 
$
1,571,745

 
$
10,876,634

 
(1)
As noted above, prior period amounts have not been adjusted under the cumulative effect method. In this table, the Company's U.S. dialysis revenues for the year ended December 31, 2017 has been presented net of the provision for uncollectible accounts of $485,364 to conform to the current period presentation.
(2)
Other consists of management service fees earned in the respective Company line of business as well as other revenue from the Company's ancillary services.